The Role of AT1R A1166C Gene Polymorphism in Coronary Slow Flow Phenomenon of Undergoing Coronary Angiography Patients

Taufik Indrajaya; Mgs Irsan Saleh; Alpian Alpian

doi:10.3889/oamjms.2020.5543

Authors

Taufik Indrajaya Department of Internal Medicine, Universitas Sriwijaya, Palembang, Indonesia
Mgs Irsan Saleh Department of Pharmacology, Faculty of Medicine, Universitas Sriwijaya, Palembang, Indonesia
Alpian Alpian Department of Internal Medicine, Universitas Sriwijaya, Palembang, Indonesia

DOI:

https://doi.org/10.3889/oamjms.2020.5543

Keywords:

coronary angiography, genetic polymorphism, genotype, gene frequency, restriction fragment length

Abstract

BACKGROUND: The presence of gene polymorphisms in the renin-angiotensin-aldosterone system associated with an impaired endothelial function that causes atherosclerosis and also myocardial fibrosis such as the polymorphism of the angiotensin-converting enzyme gene and the angiotensin I receptor (AT1R) gene.

AIM: This research was aimed to explore the role of AT1R A1166C gene polymorphism in the incidence of coronary slow flow phenomenon (CSFP) in the Malay population, South Sumatra, Indonesia.

METHODS: This study is a comparative analysis using a case-control study design to analyze the effect of the AT1R A1166C gene polymorphism on the incidence of slow flow phenomenon in patients undergoing elective coronary angiography at Mohammad Hoesin Hospital Palembang, Indonesia. Examination of AT1R gene polymorphism was carried out with several steps starting from deoxyribonucleic acid extraction, polymerase chain reaction process, followed by restriction fragment length polymorphism stages with Ddel restriction enzymes and visualization.

RESULTS: Thirty-two patients participated in these study-baseline characteristics between homogeneous coronary regular flow groups and homogeneous coronary slow flow groups. There is no difference between genotype distribution, allele frequency, and genotype between the CSFP and the coronary standard flow group.

CONCLUSION: There is no influence of AT1R A1166C gene polymorphism on the CSFP in patients undergoing coronary angiography.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Plum Analytics Artifact Widget Block

References

Beltrame JF. Defining the coronary slow flow phenomenon. Circ J. 2012;76(4):818820. PMid:22374148 DOI: https://doi.org/10.1253/circj.CJ-12-0205

Tambe AA, Demany MA, Zimmerman HA, Mascarenhas E. Angina pectoris and slow flow velocity of dye in coronary arteries-a new angiographic finding. Am Heart J. 1972;84(1):66- 71. https://doi.org/10.1016/0002-8703(72)90307-9 PMid:5080284 DOI: https://doi.org/10.1016/0002-8703(72)90307-9

Ghanie A, Indrajaya T, Ali Z, Partan RU, dan Saleh MI. Molecular diagnostic marker, “ace polymorphism gen” inpatient of slow coronary flow syndrome in Mohammad Hoesin Hospital Palembang. Acta Med. 2017;2(2):1-7.

Gibson CM, Cannon CP, Daley WL, Dodge JT, Alexander B, Marble SJ, et al. TIMI frame count: A quantitative method of assessing coronary artery flow. Circulation. 1996;93(5):879-88. https://doi.org/10.1161/01.cir.93.5.879 PMid:8598078 DOI: https://doi.org/10.1161/01.CIR.93.5.879

Mukhopadhyay S, Kumar M, Yusuf J, Gupta VK. Risk factors and angiographic profile of slow coronary flow (CSF) phenomenon in the North Indian population: An observational study. Indian Heart J. 2019;70(3):405-9. https://doi.org/10.1016/j.ihj.2017.09.001 PMid:29961458 DOI: https://doi.org/10.1016/j.ihj.2017.09.001

Sanati H, Kiani R, Shakerian F, Firouzi A, Zahedmehr A, Peighambari M, et al. Coronary slow flow phenomenon: Clinical finding and predictors. Res Cardiovasc Med. 2016;5(1):e30296. https://doi.org/10.4103/2251-9572.218699 PMid:26889458 DOI: https://doi.org/10.5812/cardiovascmed.30296

Dogan A, Oylumlu M, Kilit C, Ozgeyik M. ST-elevation myocardial infarction caused by slow coronary flow: Case report and a brief review of the literature. Int J Cardio Acad. 2016;2:52-5. https://doi.org/10.1016/j.ijcac.2015.11.003 DOI: https://doi.org/10.1016/j.ijcac.2015.11.003

Wang X, Geng LL, Nie SP. Coronary slow flow phenomenon: A local or systemic disease? Med Hypotheses. 2010;75(3):334-7. https://doi.org/10.1016/j.mehy.2010.03.016 PMid:20385447 DOI: https://doi.org/10.1016/j.mehy.2010.03.016

Sharif-Yakan A, Divchev D, Trautwein U, Nienaber CA. The coronary slow flow phenomena of “cardiac syndrome Y”: A review. Rev Vasc Med. 2014;2(1):18-22. https://doi.org/10.1016/j.rvm.2014.07.001 DOI: https://doi.org/10.1016/j.rvm.2014.07.001

Kim SK, Massett. Genetic regulation of endothelial vasomotor function. Front Physiol. 2016;571:571. PMid:27932996 DOI: https://doi.org/10.3389/fphys.2016.00571

Parchawani DN, Patel DD, Rawtani J, Yadav D. Analysis of association of angiotensin II Type-1 receptor gene A1166C gene polymorphism with essential hypertension. Ind J Clin Biochem. 2018;33(1):53-60. https://doi.org/10.1007/s12291-017-0644-7 PMid:29371770 DOI: https://doi.org/10.1007/s12291-017-0644-7

Bayramoglu A, Kurt H, Gunes HV, Ata N, Birdane A, Dikmen M, et al. Angiotensin II Type 1 receptor (AT1R) gene A1166C is associated with the risk of hypertension. Genet Test Mol Biomarkers. 2015;19(1):14-7. https://doi.org/10.1089/gtmb.2014.0233 PMid:25494405 DOI: https://doi.org/10.1089/gtmb.2014.0233

Tanriverdi H, Evrengul H, Mergen H, Acar C, Select D, Kuru O, et al. Early sign of atherosclerosis in slow coronary flow and relationship with angiotensin-converting enzyme I/D polymorphism. Heart Vessel. 2007;22(1):1-8. https://doi.org/10.1007/s00380-006-0925-1 PMid:17285438 DOI: https://doi.org/10.1007/s00380-006-0925-1

Yalcin A, Kalay N, Caglayan A, Caglayan A, Ibrahim O, Duran M, et al. The relationship between slow coronary flow and angiotensin-converting enzyme and ATIIR1 gene polymorphisms. J Natl Med Assoc. 2009;101(1):40-5. https://doi.org/10.1016/s0027-9684(15)30810-5 PMid:19245071 DOI: https://doi.org/10.1016/S0027-9684(15)30810-5

Wang X, Nie S. The coronary slow flow phenomenon: Characteristics, mechanisms and implications. Cardiovasc Diagn Ther. 2011;1(1):37-43. PMid:24282683

Amirzadegan A, Ghaderpanah R, Rayzan E, Aminorroaya A, Tajdini M. Coronary slow flow phenomenon and microalbuminuria, is there any relationship? Turk Soc Cardiol. 2019;47(8):657-61. https://doi.org/10.5543/tkda.2019.82258 PMid:31802772 DOI: https://doi.org/10.5543/tkda.2019.82258

Kalayci B, Kalayci S, Kokturk F. Proportional serum lipid parameters in coronary slow flow phenomenon. Turk Klin J Cardiovasc Sci. 2019;31(1):21-8. https://doi.org/10.5336/cardiosci.2018-63794 DOI: https://doi.org/10.5336/cardiosci.2018-63794

Wang Y, Liu MJ, Yang HM, Ma CY, Jia PY, Jia DL, et al. Association between increased serum alkaline phosphatase and the coronary slow flow phenomenon. BMC Cardiovasc Disord. 2018;18:138. https://doi.org/10.1186/s12872-018-0873-6 PMid:29973151 DOI: https://doi.org/10.1186/s12872-018-0873-6

Beltrame JF, Limaye SB, Wuttke RD. Coronary hemodynamic and metabolic studies of the coronary slow flow phenomenon. Am Heart J. 2003;146:84-90. https://doi.org/10.1016/s0002-8703(03)00124-8 PMid:12851612 DOI: https://doi.org/10.1016/S0002-8703(03)00124-8

Altun I, Akin F, Kose N, Sahin C, Kirli I. Predictors of slow flow in angiographically normal coronary arteries. Int J Clin Exp Med. 2015;8(8):13762-8.

Kalcik M, Yesin M, Guner A, Bayam E, Dogan T, Yetim M, et al. Investigation of elastic properties of aorta in patients with a slow coronary flow. J Clin Exp Investigation. 2019;10(2):1-6. https://doi.org/10.5799/jcei/5834 DOI: https://doi.org/10.5799/jcei/5834

Demir M, Demir C, Keceoglu S, Aktas I. Evaluation of plasma monocyte count in patients with a slow coronary flow. Acta Med Mediterr. 2015;13:705-9.

Gunes Y, Gumrukcuoglu HA, Akdag S, Simsek H, Sahin M, Tuncer M. Vascular endothelial function in patients with the slow coronary flow and the effects of nebivolol. Arq Bras Cardiol. 2011;97(4):275-80. https://doi.org/10.1016/s0167-5273(11)70337-0 PMid:22011806 DOI: https://doi.org/10.1590/S0066-782X2011005000105

Ozyurtlu F, Yavuz V, Cetin N, Acet H, Ayhan E, Isik T. The association between slow coronary flow and platelet distribution width among patients with stable angina pectoris. Postep Kardiol Inter. 2014;103(37):161-5. https://doi.org/10.5114/pwki.2014.45142 PMid:25489301 DOI: https://doi.org/10.5114/pwki.2014.45142

Kanar BG, Kanar HS. Relationship between angiographic coronary slow flow phenomenon and subfoveal choroidal thickness: What this effect of atorvastatin therapy? Eur J Exp Biol. 2018;8:1-6. https://doi.org/10.21767/2248-9215.100050 DOI: https://doi.org/10.21767/2248-9215.100050

Arbel Y, Rind E, Banai S, Halkin A, Berliner S, Herz I, et al. Prevalence and predictors of slow flow in angiographically normal coronary arteries. Clin Hemorheol Microcirc. 2012;52(1):5-14. https://doi.org/10.3233/ch-2012-1538 PMid:22387483 DOI: https://doi.org/10.3233/CH-2012-1538

Strain DW, Paldanius PM. Diabetes, cardiovascular disease and the microcirculation. Cardiovasc Diabetol. 2018;17:57. PMid:29669543 DOI: https://doi.org/10.1186/s12933-018-0703-2

Saya S, Hennebry TA, Lozano P, Lazzara R, Schechter E. Coronary slow flow phenomenon and risk of sudden cardiac death due to ventricular arrhythmias. Clin Cardiol. 2008;31(8):352-5. https://doi.org/10.1002/clc.20266 PMid:17957738 DOI: https://doi.org/10.1002/clc.20266

Camici PG. Angina with non-obstructed coronary arteries. Eur Heart J. 2019;21:c8-10. https://doi.org/10.1093/eurheartj/ suz047 PMid:30996699 DOI: https://doi.org/10.1093/eurheartj/suz047

Fedele F, Pucci M, Severino P. Genetic polymorphisms and ischemic heart disease. Intech. 2017;10:205-13. https://doi.org/10.5772/intechopen.69621 DOI: https://doi.org/10.5772/intechopen.69621

Shahin DS, Irshaid Y, Saleh AB. The A1166C polymorphism of AT1R gene is associated with an early onset of hypertension and high waist circumference in Jordanian males attending the Jordan university hospital. Clin Exp Hypertens. 2014;36(5):333- 9. https://doi.org/10.3109/10641963.2013.827698 PMid:24047102 DOI: https://doi.org/10.3109/10641963.2013.827698

Rai H, Sinha N. Genetic determinants and biochemical correlates of slow coronary flow: A systematic review and meta-analysis. Explor Res Hypothesis Med. 2017;2(1):12-27. https://doi.org/10.14218/erhm.2016.00010 DOI: https://doi.org/10.14218/ERHM.2016.00010

Abd El-Aziz TA, Hussein YM, Mohamed RA, Shalaby SM. Renin-angiotensin system gene polymorphism in Egyptians with premature coronary artery disease. Gene. 2012;498(2):270-5. https://doi.org/10.1016/j.gene.2012.02.033 PMid:22387727 DOI: https://doi.org/10.1016/j.gene.2012.02.033

Allen AM, Zhuo J, Mendelsohn FA. Localisation and function of angiotensin AT1 Receptors. Am J Hypertens. 2000;13(1 Pt 2):31S-8. PMid:10678286 DOI: https://doi.org/10.1016/S0895-7061(99)00249-6

Taqueti VR, Di Carli MF. Coronary microvascular disease pathogenic mechanisms and therapeutic options. J Am Coll Cardiol. 2018;27(21):2625-39. https://doi.org/10.1016/j.jacc.2018.09.042 PMid:30466521 DOI: https://doi.org/10.1016/j.jacc.2018.09.042

D’Amario D, Migliaro S, Borovac JA, Restivo A, Vergallo R, Galli M, et al. Microvascular dysfunction in heart failure with preserved ejection fraction. Front Physiol. 2019;10:1-11. https://doi.org/10.3389/fphys.2019.01347 DOI: https://doi.org/10.3389/fphys.2019.01347